Argos Soditic exits Natural Santé
French GP Argos Soditic has sold UK-based food supplements specialist Natural Santé to Spanish pharmaceutical company Cinfa.
The transaction is the third exit for Argos Soditic's Euroknights VI fund, closed on €400m in 2011. The GP is currently raising funds for Euroknights VII, with a target set at €550m and a €650m hard-cap. Argos Soditic expects a final close for Fund VII to occur imminently.
During the GP's holding period since 2013, Natural Santé's turnover grew from €32m to €46m. With the investor's backing, the company completed recruitments in sales, marketing and product development.
In 2014, Argos Soditic also backed the company's merger with Direct Plantes, specialised in the online sale and distribution of food supplements in France.
Founded in 1969 and headquartered in Huarte, Spain, Laboratorios Cinfa is a pharmaceutical company. With a current workforce of 1,000 and a turnover of around €350m, and a market coverage spanning 55 countries, Cinfa's acquisition of Natural Santé should allow it to continue to grow in the French market, the company said in a statement.
Previous funding
In 2013, Argos Soditic took a majority stake in Natural Santé through a buy-in management buyout, acquiring the company from founders Jean and Maryse Estienne. The management team invested alongside the GP and retained a minority stake.
Company
Founded around 1990, Natural Santé develops and distributes food supplements based on plants and components of natural origin, sold in pharmacies and specialist shops.
The company's head office, R&D team and logistics platform are based in Ashford, with other offices in Reignac, near Bordeaux. The group's brands notably include Santé Verte, with products such as Circulymphe, Acti'Rub and Somni'Phyt.
Natural Santé has a workforce of 150 people, and a turnover of €46m.
People
Argos Soditic – Karel Kroupa (partner); Raphaël Bazin (associate); Samuel Touboul (analyst).
Natural Santé – Philippe Hemeray (CEO).
Cinfa – Enrique Ordiered (CEO).
Advisers
Vendor – Rothschild, Pierpaolo Carpinelli, Philippe Dubois de Montreynaud (M&A); MWE, Grégoire Andrieux, Louis Leroy, Claire Barra (legal).
Buyer – Alantra, Guillermo Arbolí, Guido Siebiera, Oriane Durvye (M&A); KPMG (legal, tax, environmental & commercial due diligence).
More on Exits
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Ares Management handed keys to two-thirds of UK sponsor’s portfolio
Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported
Actera Group explores strategic options for Celebi Ground Handling
Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater